The Effect of Kinesiotaping on Posture and Balance in Patients With Postural Thoracic Hyperkyphosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

About this trial

The primary aim of our research is to evaluate the positive effects of exercise and kinesiotaping on the thoracic kyphosis angle in young adults between the ages of 18-45 with a thoracic kyphosis angle of 40 degrees and above. Secondary aims are to investigate the effects of kinesiotaping on dynamic and static balance, pain, and quality of life in patients with thoracic hyperkyphosis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being between the ages of 18-45

Among the patients who applied to the physical medicine and rehabilitation outpatient clinic with poor posture or nonspecific back pain, the kyphosis angle was measured as ≥ 40 on the thoracic lateral radiograph

Being literate

Agreeing to participate in the research

Disqualifiers

Patients younger than 18 years and older than 45 years

Spinal deformity, Scheuermann disease, disc herniation

Previous spine surgery and trauma

Neuromuscular, peripheral neuropathic disease

Trial design

Design model

Factorial

Treatments tested in this trial

  • Exercise and Kinesiotaping

    Other intervention

    Exercise and Kinesiotaping

  • Exercise

    Other intervention

    only exercise will be performed without any band treatment

  • exercise and sham taping

    Other intervention

    exercise and sham banding (banding without tension with plaster)

Treatment groups

48 Participants
are divided into 3 treatment groups
Group A: Group 1 ExerciseActive comparator 1 intervention
Group B: Group 2 Exercise and KinesiotapingActive comparator 1 intervention
Group C: Group 3 Exercise and ShamtapingSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Thoracic hyperkyphosis angle (Kyphosis Angle Measurement with Flexicurve)

They will be performed at the beginning of the study, at the end of treatment (1st month) and 1 month after the end of treatment (2nd month). Kyphosis index will be calculated with the formula: (TL/TW) x 100. Higher indices will indicate higher degrees of kyphosis. All measurements will be performed by two different specialists, repeated 2 times each and averaged. (How to measure is explained in detail in the 'detailed description' section).

Time frame
9 months

Secondary outcomes

1

Static and Dynamic Balance Measurement with Biodex Device

Balance measurement of the patients will be performed with the Biodex Balance System SD (Biodex, Inc, Shirley, NY) (BBS). BBS is a movable circular platform that can move in antero-posterior and medio-lateral axes. In our study; bilateral stance static postural stability test (level 12, stable platform), bilateral stance dynamic postural stability test (level 4, unstable platform), single leg stance postural stability test (stable platform) and stability limit test will be measured. The postural stability measurement includes the overall stability index (OSI), anteroposterior stability index (APSI) and mediolateral stability index (MLSI). High values in these scores indicate poor balance. All balance tests will be performed with eyes open and barefoot and repeated 3 times with a 10-second rest interval.

Time frame
9 months
2

Vas (Visual Analog Scale) Scoring

It will be evaluated before and at the end of treatment and at the end of the 2nd month and the patient will be asked to mark the degree of pain on a linear line with a value between 0-10.

Time frame
9 months
3

Berg Balance Scale (Turkish)

The scale consists of 14 predetermined tasks, each task achievement is scored between 0-4, and will be performed 3 times: before treatment, at the end of the 1st month and at the end of the 2nd month.

Time frame
9 months
4

SRS-22 (Turkish)

The SRS-22 questionnaire, which was developed by the Scoliosis Research Society (SRS) to be used in spinal curvatures and whose Turkish validity and reliability has been proven, will be filled out by patients before, at the end of treatment and at the 2nd month control.

Time frame
9 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.